These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7769713)

  • 21. Conformational preferences of a peptide corresponding to the major antigenic determinant of foot-and-mouth disease virus: implications for peptide-vaccine approaches.
    de Prat-Gay G
    Arch Biochem Biophys; 1997 May; 341(2):360-9. PubMed ID: 9169027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of virus neutralizing epitopes on naturally occurring variants of type A12 foot-and-mouth disease virus.
    Moore DM; Vakharia VN; Morgan DO
    Virus Res; 1989 Dec; 14(4):281-95. PubMed ID: 2483013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modified-live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimer forms of foot-and-mouth disease capsid protein epitopes on surface of hybrid virus particles.
    Kit S; Kit M; DiMarchi RD; Little SP; Gale C
    Arch Virol; 1991; 120(1-2):1-17. PubMed ID: 1718244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression in cattle of epitopes of a heterologous virus using a recombinant rinderpest virus.
    Baron MD; Foster-Cuevas M; Baron J; Barrett T
    J Gen Virol; 1999 Aug; 80 ( Pt 8)():2031-2039. PubMed ID: 10466801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection of guinea-pigs against foot-and-mouth disease virus by immunization with a PhoE-FMDV hybrid protein.
    Agterberg M; Adriaanse H; Barteling S; van Maanen K; Tommassen J
    Vaccine; 1990 Oct; 8(5):438-40. PubMed ID: 2174595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization against foot-and-mouth disease with synthetic peptides representing the C-terminal region of VP1.
    Doel TR; Gale C; Brooke G; DiMarchi R
    J Gen Virol; 1988 Sep; 69 ( Pt 9)():2403-6. PubMed ID: 2457649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigenic structure of foot and mouth disease virus type A22 (Indian isolates).
    Tulasiram P; Suryanarayana V
    Indian J Exp Biol; 1998 Jan; 36(1):70-5. PubMed ID: 9536655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A protective anti-peptide antibody against the immunodominant site of the A24 Cruzeiro strain of foot-and-mouth disease virus and its reactivity with other subtype viruses containing the same minimum binding sequence.
    Barnett PV; Pullen L; Staple RF; Lee LJ; Butcher R; Parkinson D; Doel TR
    J Gen Virol; 1996 May; 77 ( Pt 5)():1011-8. PubMed ID: 8609466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle.
    Collen T; Dimarchi R; Doel TR
    J Immunol; 1991 Jan; 146(2):749-55. PubMed ID: 1702816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of an aphthovirus chimera of the glycoprotein of vesicular stomatitis virus.
    Grigera PR; Garcia-Briones M; Periolo O; la Torre JL; Wagner RR
    J Virol; 1996 Dec; 70(12):8492-501. PubMed ID: 8970972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Synthetic immunogenic complexes containing a peptide from the surface protein of the foot-and-mouth disease virus].
    Rar VA; Makarov EA; Iurovskiĭ VV; Meshcheriakova EA; Andronova TM; Ivanov VT
    Bioorg Khim; 1990 Jul; 16(7):904-15. PubMed ID: 2173604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A high proportion of anti-peptide antibodies recognize foot-and-mouth disease virus particles.
    Parry NR; Syred A; Rowlands DJ; Brown F
    Immunology; 1988 Aug; 64(4):567-72. PubMed ID: 2844657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenic properties and population stability of a foot-and-mouth disease virus with an altered Arg-Gly-Asp receptor-recognition motif.
    Ruiz-Jarabo CM; Sevilla N; Dávila M; Gómez-Mariano G; Baranowski E; Domingo E
    J Gen Virol; 1999 Aug; 80 ( Pt 8)():1899-1909. PubMed ID: 10466785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle.
    van Lierop MJ; van Maanen K; Meloen RH; Rutten VP; de Jong MA; Hensen EJ
    Immunology; 1992 Mar; 75(3):406-13. PubMed ID: 1349300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RGD-containing peptides of VP1 of foot-and-mouth disease virus (FMDV) prevent virus infection in vitro.
    Liebermann H; Dölling R; Schmidt D; Thalmann G
    Acta Virol; 1991 Jan; 35(1):90-3. PubMed ID: 1683122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of T-cell reactivity to synthetic peptide analogues of foot-and-mouth disease virus in sheep by amino acid substitutions.
    Flynn JN; Harkiss GD; Moore D; DiMarchi R
    Vet Immunol Immunopathol; 1992 Mar; 31(3-4):255-66. PubMed ID: 1375405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants.
    Saiz JC; Gonzalez MJ; Borca MV; Sobrino F; Moore DM
    J Virol; 1991 May; 65(5):2518-24. PubMed ID: 1707983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigenic variation of foot-and-mouth disease virus of serotype C during propagation in the field is mainly restricted to only one structural protein (VP1).
    Sobrino F; Martinez MA; Carrillo C; Beck E
    Virus Res; 1989 Dec; 14(4):273-80. PubMed ID: 2560293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antigenic structure of foot-and-mouth virus. IV. Synthesis and immunogenic properties of new fragments of the VP1 protein of food-and-mouth virus strain A22].
    Iarov AV; Gel'fanov VM; Grechaninova LA; Surovoĭ AIu; Vol'pina OM; Ivanov VT; Chepurkin AV; Lugovskoĭ AA; Driagalin NN; Ivaniushchenkov VN
    Bioorg Khim; 1989 Sep; 15(9):1193-205. PubMed ID: 2556150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective immune response to foot-and-mouth disease virus with VP1 expressed in transgenic plants.
    Carrillo C; Wigdorovitz A; Oliveros JC; Zamorano PI; Sadir AM; Gómez N; Salinas J; Escribano JM; Borca MV
    J Virol; 1998 Feb; 72(2):1688-90. PubMed ID: 9445079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.